Targeted fluoromagnetic nanoparticles for imaging of breast cancer MCF-7 cells

Advanced Pharmaceutical Bulletin

Volumn 3, Issue 1, 2013, Pages 189-195

  Majd, Mostafa Heidari ^a,b,c   Barar, Jaleh ^a,d   Asgari, Davoud ^a   Valizadeh, Hadi ^a   Rashidi, Mohammad Reza ^a   Kafil, Vala ^a   Shahbazi, Javid ^a   Omidi, Yadollah ^a,d  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Breast cancer; Folate receptor; Internalization; Magnetic nanoparticles; MCF 7 cells

Indexed keywords

FOLATE RECEPTOR; MACROGOL; MAGNETIC NANOPARTICLE; MAGNETITE DOPAMINE HYDROBROMIDE POLYETHYLENE GLYCOL FLUORESCEIN ISOTHIOCYANATE NANOCONJUGATE; MAGNETITE DOPAMINE HYDROBROMIDE POLYETHYLENE GLYCOL FOLIC ACID NANOCONJUGATE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELL INTERACTION; CELL STRAIN MCF 7; CONJUGATION; DECOMPOSITION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; INFRARED SPECTROSCOPY; NANOIMAGING; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84874982615     PISSN: 22285881     EISSN: 22517308     Source Type: Journal    
DOI: 10.5681/apb.2013.031     Document Type: Article

References (32)

1. Omidi Y. Smart multifunctional theranostics: Simultaneous diagnosis and therapy of cancer. BioImpacts 2011;1(3):145-7.
2. Lee N, Hyeon T. Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. Chem Soc Rev 2012;41(7):2575-89.
3. Bu L, Xie J, Chen K, Huang J, Aguilar ZP, Wang A, et al. Assessment and comparison of magnetic nanoparticles as mri contrast agents in a rodent model of human hepatocellular carcinoma. Contrast Media Mol Imaging 2012;7(4):363-72.
4. Corr SA, Byrne SJ, Tekoriute R, Meledandri CJ, Brougham DF, Lynch M, et al. Linear assemblies of magnetic nanoparticles as mri contrast agents. J Am Chem Soc 2008;130(13):4214-5.
5. Yigit MV, Moore A, Medarova Z. Magnetic nanoparticles for cancer diagnosis and therapy. Pharm Res 2012;29(5):1180-8.
6. Tietze R, Lyer S, Durr S, Alexiou C. Nanoparticles for cancer therapy using magnetic forces. Nanomedicine (Lond) 2012;7(3):447-57.
7. Li C, Li L, Keates AC. Targeting cancer gene therapy with magnetic nanoparticles. Oncotarget 2012;3(4):365-70.
8. Ferrari M. Cancer nanotechnology: Opportunities and challenges. Nat Rev Cancer 2005;5(3):161-71.
9. Zhou J, Wu W, Caruntu D, Yu MH, Martin A, Chen JF, et al. Synthesis of porous magnetic hollow silica nanospheres for nanomedicine application. J Phys Chem C 2007;111(47):17473-7.
10. Robinson I, Tung Le, Maenosono S, Walti C, Thanh NT. Synthesis of core-shell gold coated magnetic nanoparticles and their interaction with thiolated DNA. Nanoscale 2010;2(12): 2624-30.
11. Kohler N, Fryxell GE, Zhang M. A bifunctional poly (ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents. J Am Chem Soc 2004;126(23):7206-11.
12. Shubayev VI, Pisanic TR, 2nd, Jin S. Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev 2009;61(6):467-77.
13. Bae KH, Kim YB, Lee Y, Hwang J, Park H, Park TG. Bioinspired synthesis and characterization of gadolinium-labeled magnetite nanoparticles for dual contrast t(1)- and t(2)-weighted magnetic resonance imaging. Bioconjug Chem 2010;21(3):505-12.
14. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005;26(18):3995-4021.
15. Xie J, Xu C, Kohler N, Hou Y, Sun S. Controlled pegylation of monodisperse Fe3O4 nanoparticles for reduced non-specific uptake by macrophage cells. Adv Mater 2007;19(20):3163-6.
16. Yoo HS, Park TG. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-peg-folate conjugate. J Control Release 2004;100(2):247-56.
17. Kohler N, Sun C, Wang J, Zhang M. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells. Langmuir 2005;21(19):8858-64.
18. Heidari Majd M, Asgari D, Barar J, Valizadeh H, Kafil V, Coukos G, et al. Specific targeting of cancer cells by multifunctional mitoxantrone conjugated magnetic nanoparticles. J Drug Target 2013; in press. doi: 10.3109/1061186X.2012.750325.
19. Hu FX, Neoh KG, Kang ET. Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/plla composite nanoparticles. Biomaterials 2006;27(33):5725-33.
20. Akça Ö, Ünak P, Medine EI, Özdemir Ç, Sakarya S, Timur S. Fluorescein isothiocyanate labeled, magnetic nanoparticles conjugated D-penicillamine-anti-metadherin and in vitro evaluation on breast cancer cells. Rev Bras Fisica Med 2011;5(1):99-104.
21. Zhang J, Rana S, Srivastava RS, Misra RD. On the chemical synthesis and drug delivery response of folate receptor-activated, polyethylene glycol-functionalized magnetite nanoparticles. Acta Biomater 2008;4(1):40-8.
22. Wang B, Xu C, Xie J, Yang Z, Sun S. Ph controlled release of chromone from chromone-fe3o4 nanoparticles. J Am Chem Soc 2008;130(44):14436-7.
23. Moros M, Pelaz B, Lopez-Larrubia P, Garcia-Martin ML, Grazu V, de la Fuente JM. Engineering biofunctional magnetic nanoparticles for biotechnological applications. Nanoscale 2010;2(9):1746-55.
24. Sonvico F, Mornet S, Vasseur S, Dubernet C, Jaillard D, Degrouard J, et al. Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: Synthesis, physicochemical characterization, and in vitro experiments. Bioconjug Chem 2005;16(5):1181-8.
25. Li M, Selvin PR. Amine-reactive forms of a luminescent diethylenetriaminepentaacetic acid chelate of terbium and europium: Attachment to DNA and energy transfer measurements. Bioconjug Chem 1997;8(2):127-32.
26. Kumar M, Singh G, Arora V, Mewar S, Sharma U, Jagannathan NR, et al. Cellular interaction of folic acid conjugated superparamagnetic iron oxide nanoparticles and its use as contrast agent for targeted magnetic imaging of tumor cells. Int J Nanomedicine 2012;7:3503-16.
27. Sabharanjak S, Mayor S. Folate receptor endocytosis and trafficking. Adv Drug Deliv Rev 2004;56(8):1099-109.
28. Yang J, Chen H, Vlahov IR, Cheng JX, Low PS. Evaluation of disulfide reduction during receptor-mediated endocytosis by using fret imaging. Proc Natl Acad Sci U S A 2006;103(37):13872-7.
29. Kang SM, Choi IS, Lee KB, Kim Y. Bioconjugation of poly(poly(ethylene glycol) methacrylate)-coated iron oxide magnetic nanoparticles for magnetic capture of target proteins. Macromol Res 2009;17(4):259-64.
30. Li K, Jiang Y, Ding D, Zhang X, Liu Y, Hua J, et al. Folic acid-functionalized two-photon absorbing nanoparticles for targeted mcf-7 cancer cell imaging. Chem Commun (Camb) 2011;47(26):7323-5.
31. Ferrati S, Mack A, Chiappini C, Liu X, Bean AJ, Ferrari M, et al. Intracellular trafficking of silicon particles and logic-embedded vectors. Nanoscale 2010;2(8):1512-20.
32. Barar J, Omidi Y. Cellular trafficking and subcellular interactions of cationic gene delivery nanomaterials. J Pharm Nutr Sci 2011;1(1):68-81.